Specialty Pharmacy

Myeloma Genome Project to create the largest dataset of molecular profiling for patients with multiple myeloma.

Top articles of the week on Specialty Pharmacy Times.

In a phase 3 trial, Gazyva showed superior progression-free survival in previously untreated follicular lymphoma.

Research suggests cancer cells may evade treatment by eating adult stem cells.

Top news of the day from across the health care landscape.

There is a need for the surgeons and prescribing rheumatologists to jointly address complications they may cause in RA patients.

The Institute for Safe Medication Practices works to identify the most prevalent medication safety issues and pinpoint effective strategies to reduce medication errors.

TIP60 levels could serve as a prognostic marker of breast cancer progression.

Electrodes placed into a paralyzed patient’s brain enabled her to operate a speech computer wirelessly.

An investigational drug was found to reverse the activity of immune suppressor cells.

Top news of the day from across the health care landscape.

Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.

The relationship between heart disease and rheumatoid arthritis needs deeper examination.

Finding the right combinations for antiretroviral therapy for HIV remains a challenge for researchers.

The combination of brentuximab vedotin (Adcetris) and nivolumab (Opdivo) found to be active and safe in relapsed/refractory classical Hodgkin lymphoma.

Mary Choy, of the Touro College of Pharmacy, feted for her efforts to reduce racial and ethnic disparities in health care.

ASHP honors pharmacists whose volunteer work advances the profession.

The FDA has expanded the indication of Roche’s bevacizumab (Avastin), allowing the drug to be used to treat several types of platinum-sensitive recurrent ovarian cancer.

Sterile compounding is very important for pharmacies.

New skin cancer combination therapy more effective than current treatments.

Oraxol is combination P-glycoprotein pump inhibitor and an oral version of paclitaxel.

The amount of information patients receive about disease-modifying anti-rheumatic drugs may overwhelm their memory.

Top news of the day from across the health care landscape.

New testing procedure can quickly evaluate HIV levels in the blood.

Pharmacists are always looking to identify emerging trends that will inevitably have an impact on their practice and patient care.

It is important for pharmacists to stay on top of the latest drug safety communications from the FDA, which has provided numerous ways to accomplish that task, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Specialty market growth highlighted at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2016.

Last week, the House of Representatives passed an updated version of the 21st Century Cures Act, which could have a significant impact on specialty pharmacy.

Mouth cancer rates show significant increase among males and females of all ages.

Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty pharmacies can navigate limited distribution networks.